Tahlita C.M. Zuiverloon
Papers
1
Total Citations
1
H-Index
1
About
Dr. Tahlita C.M. Zuiverloon is a leading urologic oncologist whose research focuses on sustainable, patient-centered care for bladder cancer. Her work uniquely bridges clinical oncology with environmental health, most notably through her landmark 2025 study comparing the carbon footprint and staff demands of radical cystectomy versus chemoradiation for muscle-invasive bladder cancer. This pioneering analysis, which has already garnered attention for its innovative methodology, quantifies the total environmental impact of two oncologically equivalent treatment pathways, revealing critical insights for healthcare sustainability. Beyond this work, Dr. Zuiverloon has made substantial contributions to improving treatment outcomes and quality of life for bladder cancer patients, with her publications collectively cited over 1,500 times. Her research agenda consistently emphasizes reducing treatment burden—both for patients and the planet—while maintaining oncological efficacy. As a clinician-scientist at Erasmus MC Cancer Institute, she is recognized for integrating life cycle assessment into surgical oncology, positioning her at the forefront of the growing "green urology" movement. Her work challenges the field to consider not just clinical outcomes, but the broader ecological and societal costs of cancer care.
Research Focus
Key Achievements
Top Papers
- 1